BiotechTube

mirabegron + metoprolol

Phase 1Completed
1 views this week 0 watching💤 Quiet
Interest: 29/100
29
Hype Score

Development Stage

✓
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Pharmacokinetics of Mirabegron

Conditions

Pharmacokinetics of Mirabegron, Healthy Subjects

Trial Timeline

Sep 1, 2002 → Nov 1, 2002

NCT ID
NCT01478490

About mirabegron + metoprolol

mirabegron + metoprolol is a phase 1 stage product being developed by Astellas Pharma for Pharmacokinetics of Mirabegron. The current trial status is completed. This product is registered under clinical trial identifier NCT01478490. Target conditions include Pharmacokinetics of Mirabegron, Healthy Subjects.

What happened to similar drugs?

5 of 5 similar drugs in Pharmacokinetics of Mirabegron were approved

Approved (5) Terminated (0) Active (0)
✅tolterodine + mirabegronAstellas PharmaApproved
✅mirabegronAstellas PharmaApproved
✅Prograf + Tacrolimus HexalNovartisApproved
✅Aripiprazole + Aripiprazole + desvenlafaxine succinate sustained releasePfizerApproved
✅Tamoxifen + Tamoxifen and Desvenlafaxine Succinate Sustained ReleasePfizerApproved

Hype Score Breakdown

Clinical
6
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT01478490Phase 1Completed

Competing Products

20 competing products in Pharmacokinetics of Mirabegron

See all competitors
ProductCompanyStageHype Score
DFD-29 (Minocycline) Fasting + DFD-29 (Minocycline) Fed + Solodyn (Minocycline) FastingDr. Reddy's LaboratoriesPhase 1
26
DRL_PG + Pegfilgrastim Form A + Pegfilgrastim Form BDr. Reddy's LaboratoriesPhase 1
22
GP30341 capsules 200 mg + Standard therapyGEROPHARMPre-clinical
16
GP40221 + ozempicGEROPHARMPhase 1
19
Memantinol tablets, 20 mg + Akatinol Memantine® tablets, 20 mgGEROPHARMPhase 1
19
Rinsulin NPH + Humulin NPHGEROPHARMPre-clinical
16
Crestor 10mg(Rosuvastatin 10mg), Glucodown OR SR 750mg(Metformin SR 750mg)YuhanPhase 1
29
DS-8500a + ItraconazoleDaiichi SankyoPhase 1
29
Milademetan + Itraconazole + PosaconazoleDaiichi SankyoPhase 1
29
Pexidartinib + ProbenecidDaiichi SankyoPhase 1
29
DS-8500a + RosuvastatinDaiichi SankyoPhase 1
29
DS-8500aDaiichi SankyoPhase 1
29
Milademetan Treatment A + Milademetan Treatment B + Milademetan Treatment CDaiichi SankyoPhase 1
29
tolterodine + mirabegronAstellas PharmaApproved
43
ASP3652Astellas PharmaPhase 1
29
ASP015K ER + ASP015K IRAstellas PharmaPhase 1
29
YM178 modified release (OCAS) + YM178 immediate release (IR)Astellas PharmaPhase 1
29
Isavuconazole + dextromethorphanAstellas PharmaPhase 1
29
ASP015KAstellas PharmaPhase 1
29
zolbetuximab + oxaliplatin + leucovorin + fluorouracil + Pembrolizumab + folinic acid + nivolumab + DocetaxelAstellas PharmaPhase 2
39